Josh Lehrer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Josh Lehrer
Josh Lehrer is recorded as COO at Lisata Therapeutics, Inc. (LSTA). Lisata Therapeutics, Inc. reported in an 8-K filed September 17, 2026 that Josh Lehrer was appointed newly appointed Chief Operating Officer and President of Lisata Therapeutics and Chief Executive Officer of Marea.
“"This transaction provides the combined company with the resources to advance our two clinical stage drug candidates through pivotal milestones, including MAR001 topline Phase 2b data in severe hypertriglyceridemia and MAR002 Phase 2 proof of concept data in patients with acromegaly next year, as well as initiation of Phase 3 registrational studies for both programs," said Dr. Josh Lehrer, newly appointed Chief Operating Officer and President of Lisata Therapeutics and Chief Executive Officer of Marea.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-17–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lisata Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Mazzo CEO
- David J. Mazzo, Ph.D. CEO
- David Mazzo CEO, Board Member
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.